Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 6 Resistance of gram positive cocci to various antimicrobials

From: Emerging antimicrobial resistance in early and late-onset neonatal sepsis

Organism (number) Ampicillin-sulbactam Amikacin Cefotaxime Ceftazidime Imipenem Vancomycin Ciprofloxacin Clindamycin Polymyxin Rifampicin Piperacillin-tazobactam
CONS (33) 33(100%) 16(48.5%) 31(93.9%) 31(93.9%) 28(84.8%) 8(24.2%) 25(75.8%) 18(55%) ND 15(46%) 33(100%)
MRSA (9) 9(100%) 3(33.3%) 9(100%) 9(100%) 8(88.9%) 0 8(88.9%) 3(33%) ND 3(33%) 9(100%)
B streptococcus (4) 4(100%) 2(50%) 3(75%) 3(75%) 2(50%) 1(25%) 3(75%) 3(75%) ND 4(100%) 4(100%)
St. pneumonie (1) 1(100%) 1(100%) 1(100%) 1(100%) 1(100%) 0 0 1(100%) ND 1(100%) 1(100%)
Staph aureus (4) 4(100%) 3(75%) 4(100%) 4(100%) 4(100%) 0 3(75%) 2(50%) ND 2(50%) 4(100%)
  Gentamicin Meropenem Cefoperazone Cefepime Amoxicillin-clavulanate Ceftriaxone Cotrimoxazole Erythromycin Cefoxitin Levofloxacin Cefuroxime
CONS (33) 18(55%) 28(85%) 33(100%) 29(88%) 26(79%) 33(100%) 27(82%) 28(85%) 25(76%) 22(67%) 33(100%)
MRSA (9) 7(77.8%) 9(100%) 9(100%) 9(100%) 9(100%) 9(100%) 8(89%) 7(78%) 9(100%) 7(78%) 9(100%)
B streptococcus (4) 0 2(50%) 4(100%) 2(50%) 3(75%) 4(100%) 4(100%) 4(100%) 3(75%) 4(100%) 4(100%)
St. pneumonie (1) 0 1(100%) 1(100%) 0 0 1(100%) 1(100%) 1(100%) 1(100%) 1(100%) 1(100%)
Staph aureus (4) 4(100%) 4(100%) 4(100%) 4(100%) 0 4(100%) 4(100%) 4(100%) 3(75%) 4(100%) 4(100%)
  1. ND sensitivity was not done, CONS coagulase negative staphylococci, MRSA methicillin resistant staphylococcus aureus, St streptococcus, Staph. aureus Staphylococcus aureus